Target intelligence / Profile preview

RNA, U6 small nuclear 1041, pseudogene (RNU6-1041P)

Target
RNU6-1041P
Molecular classification
Unprocessed pseudogene, Non-coding RNA, Small nuclear RNA pseudogene, Long non-coding RNA precursor (potentially, by analogy to other pseudogenes)
01

Overview

RNU6-1041P is a human pseudogene corresponding to the U6 small nuclear RNA family. It is classified as a non-coding RNA pseudogene, meaning it contains sequence similarity to an ancestral U6 snRNA gene but lacks protein-coding potential and canonical snRNA function. Pseudogenes like this may theoretically influence gene expression via RNA-mediated mechanisms (such as antisense regulation, miRNA sponging, or lncRNA production), but no experimental evidence supports a specific role for RNU6-1041P. The molecule is not considered a receptor, enzyme, transporter, or traditional therapeutic target, and it is often omitted from drug-target databases. There is nothing to indicate therapeutic relevance, drug interaction, or disease association, nor is it a recognized biomarker. The name is accurate as a gene symbol and description, but it is not a canonical therapeutic target, not an enzyme, nor a receptor, and is best classified as a pseudogene. There is no evidence of misspelling or ambiguity, but its functional role is largely theoretical and unsupported for this specific pseudogene, so for therapeutic targeting or drug development, it is not relevant.

Other names
RNU6-1041PRNA, U6 small nuclear 1041, pseudogene
02

Mechanism of action

None known directly. In principle, pseudogene-derived lncRNAs or antisense RNAs can act as gene expression regulators, miRNA sponges, or epigenetic modulators, but this is unresearched or unreported for RNU6-1041P specifically.

03

Biological functions

As with many pseudogenes, there is no canonical protein-coding functionMay contribute regulatory non-coding RNAs (lncRNAs, antisense RNAs) influencing gene expression in principlePossible involvement as a miRNA sponge, but this has not been directly shown for RNU6-1041P; observed in other pseudogenes
04

Disease associations

No experimentally validated link of RNU6-1041P to disease states.Pseudogenes of other families have been implicated in cancer, but not specifically RNU6-1041P
05

Safety considerations

None known; not a therapeutic or drug target.
06

Interacting drugs

None currently known or described.
07

Biomarkers

None established for RNU6-1041P.

Beyond the preview

Go deeper on RNA, U6 small nuclear 1041, pseudogene (RNU6-1041P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1041, pseudogene (RNU6-1041P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call